Article PDF
References
Lasne D, Jude B, Susen S. From normal to pathological hemostasis. Can J Anesth 2006; 53(6 Suppl): S2–11.
Hardy JF, De Moerloose P, Samama M;Groupe d’Intérêt en Hémostase Périopératoire. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anesth 2004; 51: 293–310.
Holte K, Sharrock NE, Kehlet H. Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth 2002; 89: 622–32.
Karkouti K, Yau TM, Riazi S, et al. Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery. Can J Anesth 2006; 53: 802–9.
Ozier Y, Schlumberger S. Pharmacological approaches to reducing blood loss and transfusions in the surgical patient. Can J Anesth 2006; 53(6 Suppl): S21–9.
Lecompte T, Hardy JF. Antiplatelet agents and perioperative bleeding. Can J Anesth 2006; 53(6 Suppl): S103–12.
Motte S, Samama CM, Guay J, Barre J, Borg JY, Rosencher N. Prevention of postoperative venous thromboembolism. Risk assessment and methods of prophylaxis. Can J Anesth 2006; 53(Suppl): S68–79.
de Maistre E, Gruel Y, Lasne D. Diagnosis and management of heparin-induced thrombocytopenia. Can J Anesth 2006; 53(6 Suppl): S123–34.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karkouti, K., Dattilo, K.M. Perioperative hemostasis and thrombosis. Can J Anesth 53, 1260–1262 (2006). https://doi.org/10.1007/BF03021588
Issue Date:
DOI: https://doi.org/10.1007/BF03021588